Irina Kontsevaya Selected Research

Irina Kontsevaya Research Topics

13	Tuberculosis (Tuberculoses) 05/2024 - 04/2012
3	Pulmonary Tuberculosis 02/2024 - 10/2020
2	Infections 05/2023 - 01/2020
2	Extensively Drug-Resistant Tuberculosis 01/2013 - 04/2012
1	Injection Site Reaction 05/2023
1	COVID-19 10/2021
1	Disease Progression 06/2021
1	Multiple Organ Failure (MODS) 03/2020

4	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2015
4	Rifampin (Rifampicin)FDA LinkGeneric 02/2024 - 03/2020
2	Kanamycin FDA Link 03/2014 - 01/2013
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2023
1	Ertapenem (Invanz)FDA Link 10/2023
1	Meropenem (Merrem)FDA LinkGeneric 10/2023
1	AntigensIBA 05/2023
1	Tuberculin (PPD)IBA 05/2023
1	InterferonsIBA 05/2023
1	tocilizumab (atlizumab)FDA Link 10/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 03/2020
1	AgarIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	propidium monoazideIBA 03/2015
1	Biological FactorsIBA 03/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2012
1	FluoroquinolonesIBA 04/2012